Arete Wealth Advisors’s Zevra Therapeutics ZVRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $659K | Sell |
|
|||||
|
2025
Q1 | $561K | Sell |
|
|||||
|
2024
Q4 | $649K | Hold |
|
|||||
|
2024
Q3 | $545K | Sell |
|
|||||
|
2024
Q2 | $374K | Sell |
|
|||||
|
2024
Q1 | $459K | Sell |
|
|||||
|
2023
Q4 | $527K | Sell |
|
|||||
|
2023
Q3 | $389K | Buy |
|
|||||
|
2023
Q2 | $406K | Sell |
|
|||||
|
2023
Q1 | $453K | Hold |
|
|||||
|
2022
Q4 | $378M | Buy |
|
|||||
|
2022
Q3 | $490K | Sell |
|
|||||
|
2022
Q2 | $353K | Buy |
|
|||||
|
2022
Q1 | $382K | Buy |
|
|||||
|
2021
Q4 | $564K | Buy |
|
|||||
|
2021
Q3 | $527K | Buy |
|
|||||
|
2021
Q2 | $723K | Buy |
|
|||||
|
2021
Q1 | $486K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $193K | Buy |
|
|||||
|
2020
Q1 | $136K | Buy |
|
|||||
|
2019
Q4 | $219K | Buy |
|
|||||
|
2019
Q3 | $381K | Buy |
|
|||||
|
2019
Q2 | $896K | Buy |
|
|||||
|
2019
Q1 | $831K | Sell |
|
|||||
|
2018
Q4 | $961K | Buy |
|
|||||
|
2018
Q3 | $2.45M | Sell |
|
|||||
|
2018
Q2 | $3.35M | Sell |
|
|||||
|
2018
Q1 | $4.43M | Sell |
|
|||||
|
2017
Q4 | $3.31M | Sell |
|
|||||
|
2017
Q3 | $3.09M | Sell |
|
|||||
|
2017
Q2 | $3.41M | Buy |
|
|||||
|
2017
Q1 | $4.17M | Buy |
|
|||||
|
2016
Q4 | $2.51M | Buy |
|
|||||
|
2016
Q3 | $3.75M | Buy |
|
|||||
|
2016
Q2 | $3.29M | Sell |
|
|||||
|
2016
Q1 | $15.1M | Buy |
|
|||||
|
2015
Q4 | $19.6M | Buy |
|